Trend in mortality from chronic kidney disease in Brazil and its regions, 2013-2023: an ecological time-series study

Authors

  • João Paulo de Morais Sonda Universidad Central del Paraguay, Ciudad del Este, Paraguay Autor/a
  • Juliana Barbosa Lima Ribeiro Universidad Central del Paraguay, Ciudad del Este, Paraguay Autor/a
  • Silvia Carolina Castro Sampaio Universidad Central del Paraguay, Ciudad del Este, Paraguay Autor/a
  • Ramón Mario Bellón Préstamo Universidad Central del Paraguay, Ciudad del Este, Paraguay Autor/a

DOI:

https://doi.org/10.5281/zenodo.22150016

Keywords:

renal insufficiency, chronic, mortality, time series studies, healthcare disparities, Brazil, epidemiology

Abstract

Introduction: Chronic kidney disease affects more than 10% of the world population and its mortality has increased over the past two decades. In Brazil an upward trend with sociodemographic disparities has been described. The aim was to analyze the trend in mortality from chronic kidney disease in Brazil and its five macro-regions between 2013 and 2023, by sex and age group. Materials and methods: Ecological time-series study with deaths whose underlying cause was chronic kidney disease (ICD-10 code N18) from the Mortality Information System, and population denominators from the Brazilian Institute of Geography and Statistics. Rates per 100,000 inhabitants were calculated and the mean annual change was estimated by simple linear regression, with significance at p < 0.05. Results: 83,787 deaths were recorded; 57.5% were men and 32.9% were people aged 80 years or older. The national rate rose from about 3.5 to 4.0 per 100,000 inhabitants, with a mean annual increase of 0.090 per 100,000 (95% confidence interval: 0.053 to 0.126; p < 0.001). All five macro-regions showed a significant upward trend. Conclusions: In Brazil mortality from chronic kidney disease increased between 2013 and 2023, concentrated in men and older people and widespread across all regions. Because of its ecological design with aggregated data, the study describes the trend but does not allow establishment of its causes; the findings support strengthening detection in primary care and reducing regional inequalities in access to nephrological care.

References

Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238-52.

Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398(10302):786-802.

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7-11.

Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473-85.

GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-33.

Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease Study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567-81.

Bowe B, Xie Y, Li T, Mokdad AH, Xian H, Yan Y, et al. Changes in the US burden of chronic kidney disease from 2002 to 2016: an analysis of the Global Burden of Disease Study. JAMA Netw Open. 2018;1(7):e184412.

Johansen KL, Chertow GM, Foley RN, Gilbertson DT, Herzog CA, Ishani A, et al. US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2021;77(4 Suppl 1):A7-8.

Gouvêa EDCDP, Ribeiro AM, Aquino EC, Stopa SR. Mortality trend due to chronic kidney disease in Brazil: an ecological study. Epidemiol Serv Saude. 2023;32(3):e2023313.

Hauwanga WN, Alphonse B, Akram I, Djeagou A, Lima Pessôa B, McBenedict B. Decadal analysis of age-adjusted mortality rates for acute and chronic kidney disease in Brazil, 2000-2021. Cureus. 2024;16(6):e61657.

de Souza W, de Abreu LC, Silva LGD, Bezerra IMP. Incidence of chronic kidney disease hospitalisations and mortality in Espírito Santo between 1996 to 2017. PLoS One. 2019;14(11):e0224889.

Nerbass FB, Lima HDN, Moura-Neto JA, Lugon JR, Sesso R. Brazilian Dialysis Survey 2022. J Bras Nefrol. 2024;46(2):e20230062.

Samaan F, Clemente ÁMI, Zaicaner R, Kirsztajn GM, Sesso R. Registry of access to chronic dialysis initiation at the Public Health System in Brazil. Int Urol Nephrol. 2025;58(1):209-18.

Cobo B, Cruz C, Dick PC. Gender and racial inequalities in the access to and the use of Brazilian health services. Cien Saude Colet. 2021;26(9):4021-32.

Charles C, Ferris AH. Chronic kidney disease. Prim Care. 2020;47(4):585-95.

Liu P, Quinn RR, Lam NN, Elliott MJ, Xu Y, James MT, et al. Accounting for age in the definition of chronic kidney disease. JAMA Intern Med. 2021;181(10):1359-66.

Major RW, Cheng MRI, Grant RA, Shantikumar S, Xu G, Oozeerally I, et al. Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2018;13(3):e0192895.

Ebert T, Pawelzik SC, Witasp A, Arefin S, Hobson S, Kublickiene K, et al. Inflammation and premature ageing in chronic kidney disease. Toxins (Basel). 2020;12(4):227.

Pan XF, Yang J, Wen Y, Li N, Chen S, Pan A. Non-communicable diseases during the COVID-19 pandemic and beyond. Engineering (Beijing). 2021;7(7):899-902.

Published

2025-12-30

Issue

Section

Original Articles

How to Cite

Trend in mortality from chronic kidney disease in Brazil and its regions, 2013-2023: an ecological time-series study. (2025). Revista UniNorte De Medicina Y Ciencias De La Salud, 14(3), 129–133. https://doi.org/10.5281/zenodo.22150016

Similar Articles

11-20 of 85

You may also start an advanced similarity search for this article.